Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411630 · ClinicalTrials.gov registry record
Factors Affecting PrEP Adherence
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 167
- Enrollment target
NCT02411630: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02411630 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 167 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411630 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have sex with men (YMSM) who are taking PrEP as part of another study, either ATN 110 or ATN 113.
Primary Outcome
To assess preference of the iQS as a way to measure adherence to Pre-Exposure Prophylaxis (PrEP) in PrEP clinical trials, completion rates; pattern of skipped or incomplete responses by variables will be analyzed.
Interventions
- DRUG Emtricitabine/tenofovir disoproxil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-06 |
What the finished NCT02411630 record still lists
NCT02411630 is an observational study that tracks outcomes without assigning an intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Emtricitabine/tenofovir disoproxil is the first listed.
NCT02411630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411630 about?
NCT02411630 is a clinical study titled "Factors Affecting PrEP Adherence". The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have se...
What is the current status of trial NCT02411630?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2013-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02411630?
The interventions under investigation include: Emtricitabine/tenofovir disoproxil (DRUG).
Who is sponsoring clinical trial NCT02411630?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia